Molecular therapeutics : Methotrexate and its mechanism of actionCRONSTEIN, B. N.Arthritis and rheumatism. 1996, Vol 39, Num 12, pp 1951-1960, issn 0004-3591Article

Adenosine, and endogenous anti-inflammatory agentCRONSTEIN, B. N.Journal of applied physiology (1985). 1994, Vol 76, Num 1, pp 5-13, issn 8750-7587Article

Clinical use of methylprednisolone sodium succinate : a reviewCRONSTEIN, B. N.Current therapeutic research. 1995, Vol 56, Num 1, pp 1-15, issn 0011-393XArticle

Molecular mechanism of methotrexate action in inflammationCRONSTEIN, B. N.Inflammation. 1992, Vol 16, Num 5, pp 411-423, issn 0360-3997Article

Fcγ receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy : A1 receptors are stimulatory and A2 receptors inhibitorySALMON, J. E; CRONSTEIN, B. N.The Journal of immunology (1950). 1990, Vol 145, Num 7, pp 2235-2240, issn 0022-1767Article

Age-related changes in neutrophil structure and functionPERSKIN, M. H; CRONSTEIN, B. N.Mechanisms of ageing and development. 1992, Vol 64, Num 3, pp 303-313, issn 0047-6374Article

The antiinflammatory mechanism of methotrexate : increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammationCRONSTEIN, B. N; NAIME, D; OSTAD, E et al.The Journal of clinical investigation. 1993, Vol 92, Num 6, pp 2675-2682, issn 0021-9738Article

Stimulus-response uncoupling in the neutrophil : adenosine A₂-receptor occupancy inhibits the sustained, but not the early, events of stimulus transduction in human neutrophils by a mechanism independent of actin-filament formationCRONSTEIN, B. N; HAINES, K. A.Biochemical journal (London. 1984). 1992, Vol 281, pp 631-635, issn 0264-6021, 3Article

Adenosine, a cytoprotective autocoid: effects of adenosine on neutrophil plasma membrane viscosity and chemoattractant receptor displayCRONSTEIN, B. N; ROSE, F. R; PUGLIESE, C et al.Biochimica et biophysica acta. 1989, Vol 987, Num 2, pp 176-180, issn 0006-3002Article

Adenosine deaminase is not required for the generation of superoxide anionCRONSTEIN, B. N; KRAMER, S. B; WEISSMANN, G et al.Clinical immunology and immunopathology (Print). 1984, Vol 30, Num 3, pp 495-499, issn 0090-1229Article

Systemic lupus erythematosus in a patient with Reiter's syndromeAISEN, P. S; CRONSTEIN, B. N; KRAMER, S. B et al.Arthritis and rheumatism. 1983, Vol 26, Num 11, pp 1405-1408, issn 0004-3591Article

Occupancy of G_αs-linked receptors uncouples chemoattractant receptors from their stimulus-transduction mechanisms in the neutrophilCRONSTEIN, B. N; HAINES, K. A; KOLASINKI, S et al.Blood. 1992, Vol 80, Num 4, pp 1052-1057, issn 0006-4971Article

Adenosine promotes neutrophil chemotaxisROSE, F. R; HIRSCHHORN, R; WEISSMANN, G et al.The Journal of experimental medicine. 1988, Vol 167, Num 3, pp 1186-1194, issn 0022-1007, 9 p.Article

Adenosine A_2A receptors in diffuse dermal fibrosis : Pathogenic role in human dermal fibroblasts and in a murine model of sclerodermaCHAN, E. S. L; FERNANDEZ, P; TOMIC-CANIC, M et al.Arthritis and rheumatism. 2006, Vol 54, Num 8, pp 2632-2642, issn 0004-3591, 11 p.Article

Neuropeptides and inflammation : a somatostatin analog as a selective antagonists of neutrophil activation by substance PKOLASINSKI, S. L; HAINES, K. A; SIEGEL, E. L et al.Arthritis and rheumatism. 1992, Vol 35, Num 4, pp 369-375, issn 0004-3591Article

Role of P1 receptors in inflammationMON'TESINOS, M. C; CRONSTEIN, B. N.Handbook of experimental pharmacology. 2001, Vol 151, pp 303-321, issn 0171-2004, 2Article

The antirheumatic agents sulphasalazine and methotrexate share and anti-inflammatory mechanismCRONSTEIN, B. N.British journal of rheumatology. 1995, Vol 34, pp 30-32, issn 0263-7103, SUP2Conference Paper

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cellsCRONSTEIN, B. N; LEVIN, R. I; BELANOFF, J et al.The Journal of clinical investigation. 1986, Vol 78, Num 3, pp 760-770, issn 0021-9738Article

The adenosine/neutrophil paradox resolved : human neutrophils possess both A ₁ and A₂ receptors that promote chemotaxis and inhibit O₂^- generation, respectivelyCRONSTEIN, B. N; DAGUMA, L; NICHOLS, D et al.The Journal of clinical investigation. 1990, Vol 85, Num 4, pp 1150-1157, issn 0021-9738Article

Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsiaBUYON, J. P; CRONSTEIN, B. N; MORRIS, M et al.The American journal of medicine. 1986, Vol 81, Num 2, pp 194-200, issn 0002-9343Article

Immunocomplexes stimulate different signalling events to chemoattractants in the neutrophil and regulate L-selectin and β₂-integrin expression differentlyYAIR MOLAD; HAINES, K. A; ANDERSON, D. C et al.Biochemical journal (London. 1984). 1994, Vol 299, pp 881-887, issn 0264-6021, 3Article

Neutrophil chemotaxis in response to TGF-β isoforms (TGF-β1, TGF-β2, TGF-β3) is mediated by fibronectinPAREKH, T; SAXENA, B; REIBMAN, J et al.The Journal of immunology (1950). 1994, Vol 152, Num 5, pp 2456-2466, issn 0022-1767Article

A mechanism for the antiinflammatory effects of corticosteroids : the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1CRONSTEIN, B. N; KIMMEL, S. C; LEVIN, R. I et al.Proceedings of the National Academy of Sciences of the United States of America. 1992, Vol 89, Num 21, pp 9991-9995, issn 0027-8424Article

Adenosine: a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A₂ receptor on human neutrophilsCRONSTEIN, B. N; ROSENSTEIN, E. D; KRAMER, S. B et al.The Journal of immunology (1950). 1985, Vol 135, Num 2, pp 1366-1371, issn 0022-1767Article

Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine : Evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritisMONTESINOS, M. C; YAP, J. S; DESAI, A et al.Arthritis and rheumatism. 2000, Vol 43, Num 3, pp 656-663, issn 0004-3591Article